Are Placebo-Controlled, Relapse Prevention Trials in Schizophrenia Research Still Necessary or Ethical?

Are Placebo-Controlled, Relapse Prevention Trials in Schizophrenia Research Still Necessary or Ethical?

This Viewpoint discusses the implications of placebo-controlled, relapse prevention trials in schizophrenia research and suggests that continuing such trials may no longer be necessary or ethical.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA psychiatry (Chicago, Ill.) Ill.), 2019-07, Vol.76 (7), p.673-674
Hauptverfasser: Lawrence, Ryan E, Appelbaum, Paul S, Lieberman, Jeffrey A
Format: Artikel
Sprache:eng
Schlagworte:
Clinical trials
Ethics
Medical ethics
Placebo effect
Schizophrenia
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This Viewpoint discusses the implications of placebo-controlled, relapse prevention trials in schizophrenia research and suggests that continuing such trials may no longer be necessary or ethical.
ISSN:2168-622X
2168-6238
DOI:10.1001/jamapsychiatry.2019.0275